Maurie Markman

Philadelphia

Contributor at OncLive

President of Medicine and Science @CancerCenter #TreatThePerson #Oncology #Genomics #PrecisionMedicine

Articles

AI in Healthcare Faces Growing Skepticism Among Patients

2 weeks ago | medscape.com | Maurie Markman

This transcript has been edited for clarity. Hello. I'm Dr Markman, from City of Hope. I'd like to briefly discuss two separate but related articles that recently appeared, which touch on the evolving and critically important topic of artificial intelligence.
Cancer’s Toll Raises Suicide Risk for Spouses

2 weeks ago | medscape.com | Maurie Markman

This transcript has been edited for clarity. Hello. I'm Dr Maurie Markman from City of Hope. I'd like to briefly discuss a very difficult topic, but one that I believe needs to be more openly discussed — not necessarily the specifics of the topic, but the implications of findings. The paper I'm referring to is entitled, “Suicide attempt and suicide death among spouses of patients with cancer.” This was reported in JAMA Oncology. What we're looking at here in this analysis are data from Denmark.
On the Unreality of Cancer Care Finances in the US: An Example of the Emperor's New Clothes Syndrome?

3 weeks ago | onclive.com | Maurie Markman

his commentator could think of no better way to begin a brief discussion addressing the current unreality of cancer care finances in the US than to invoke the theme of Hans Christian Andersen’s famous childhood tale “The Emperor’s New Clothes.”1 “Oh, how beautiful are our Emperor’s new clothes.... In fact, no one would admit that he could not see these clothes, which everyone seemed to think so beautiful, for fear he would be called a simpleton or unfit for his office....
Multigene Testing in Pancreatic Cancer: NCCN Impact

3 weeks ago | medscape.com | Maurie Markman

This transcript has been edited for clarity. Hello. I'm Dr Maurie Markman, from City of Hope. I'd like to present a very interesting analysis. I think it’s open to interpretation, and follow up of what I'm going to discuss is necessary, but I think it makes a number of important points relative to the question of optimal utilization o f multi-panel molecular testing as we move forward in this very exciting world of targeted therapy.
Olaparib Shows Strong Results in Recurrent Prostate Cancer

1 month ago | medscape.com | Maurie Markman

This transcript has been edited for clarity. Hello. I’m Dr Maurie Markman, from City of Hope. I’d like to briefly discuss a small study, not a large, randomized, controlled clinical trial. One may ask, how do you draw major conclusions on a small trial, which I’ll identify in a moment.
El ejercicio mejora la calidad de vida y la fatiga en el cáncer de mama metastásico

1 month ago | espanol.medscape.com | Maurie Markman

close ¿Está seguro que quiere cerrar su sesión? Hola, soy el Dr. Maurie Markman, de City of Hope, Estados Unidos. En esta ocasión comentaré brevemente un tema muy provocativo e importante relacionado con la prevención secundaria del cáncer.
Exercise Improves Quality of Life in Metastatic Cancer

1 month ago | medscape.com | Maurie Markman

This transcript has been edited for clarity. Hello. I'm Dr Maurie Markman, from City of Hope. I want to briefly discuss a very provocative, important topic related to secondary cancer prevention. This was a paper published in Nature Medicine, entitled, “Supervised, Structured and Individualized Exercise in Metastatic Breast Cancer: A Randomized Controlled Trial.”We all know exercise is important.
Older Adults’ Cancer Risk Rises With Any Alcohol Use

1 month ago | medscape.com | Maurie Markman

This transcript has been edited for clarity. Hello. I'm Dr Maurie Markman, from City of Hope. I want to briefly discuss a very interesting paper that is probably a bit controversial, but nevertheless, I want to point out the data. The paper is “Alcohol Consumption Patterns and Mortality Among Older Adults With Health-Related or Socioeconomic Risk Factors,” published in JAMA Network Open.
"Halfway Technology": Is It Time to Seriously Discuss Transitioning From the Current Focus of Cancer Research?

1 month ago | onclive.com | Maurie Markman

It was more than 50 years ago in his elegant lay book, The Lives of a Cell, that the late eminent physician-scientist, administrator, and author Lewis Thomas described rather starkly and quite accurately the particular focus of both clinical medicine and clini- cal investigation over the succeeding decades, including within the domain of cancer management.1 In a chapter titled “The Technology of Medicine,” Thomas defines the term halfway technology, which “represents the kinds of things that...
Fast Five Quiz: CAR T-Cell Therapy for Multiple Myeloma

2 months ago | reference.medscape.com | Maurie Markman

closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Chimeric antigen receptor (CAR) T-cell therapy has revolutionized treatment for multiple myeloma, with trials showing it can achieve high response rates in refractory or resistant cases and among patients with severe disease.